4.4 Editorial Material

Why Exceptional Public Investment in the Development of Vaccines Is Justified for COVID-19, But Not for Other Unmet Medical Needs COMMENT

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ethics

Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?

Holly Fernandez Lynch et al.

Summary: The response to the COVID-19 pandemic has provided valuable lessons for addressing non-pandemic diseases, emphasizing the importance of collaboration, supporting critical research, innovative trial designs, and rapid information sharing. However, lowering regulatory standards may lead to safety concerns, missed research opportunities, and delays in determining effective treatments. Policymakers and patient advocates should focus on promoting robust research designs, improving access to clinical trials, and facilitating use of existing pathways for unmet treatment needs in non-pandemic diseases.

AMERICAN JOURNAL OF BIOETHICS (2021)

Editorial Material Medicine, General & Internal

The Leading Causes of Death in the US for 2020

Farida B. Ahmad et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Public, Environmental & Occupational Health

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Multidisciplinary Sciences

The effect of large-scale anti-contagion policies on the COVID-19 pandemic

Solomon Hsiang et al.

NATURE (2020)